Innovage Holding Revenue Growth Rates (INNV), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Innovage Holding Corp   (NASDAQ: INNV)
 

INNV's Revenue Growth by Quarter and Year

Innovage Holding 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

INNV Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter June 261.95
3rd Quarter March 251.94
2nd Quarter December 239.71
1st Quarter September 236.11
FY 989.71

INNVs Annual Revenue
Innovage Holding 's Revenue in the fiscal year 2026 $ 989.71 millions
Innovage Holding 's Revenue in the fiscal year 2025 $ 853.70 millions
Innovage Holding 's Revenue in the fiscal year 2024 $ 763.86 millions
Innovage Holding 's Revenue in the fiscal year 2023 $ 688.09 millions
Innovage Holding 's Revenue in the fiscal year 2022 $ 698.64 millions




INNV Revenue fourth quarter 2025 Y/Y Growth Comment
Innovage Holding Corp reported Revenue increase of 18.31% year on year in the fourth quarter 2025, to $ 261.95 millions, this is lower than Innovage Holding Corp 's recent average Revenue surge of 237.64%.

Looking into fourth quarter 2025 results within Medical Equipment & Supplies industry 124 other companies have achieved higher Revenue growth. While Innovage Holding Corp ' s Revenue growth of 18.31% ranks overall at the positon no. 2348 in the fourth quarter 2025.


INNV Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter June 18.31 % 11.04 % 12.74 % 2.32 %
3rd Quarter March 15.49 % 12.98 % 11.9 % -2.72 %
2nd Quarter December 14.69 % 10.64 % 12.8 % -4.5 %
1st Quarter September 15.1 % 12.41 % 6.58 % -1.07 %
FY   15.93 % 11.76 % 11.01 % -

Financial Statements
Innovage Holding 's fourth quarter 2025 Revenue $ 261.95 millions INNV's Income Statement
Innovage Holding 's fourth quarter 2024 Revenue $ 221.42 millions Quarterly INNV's Income Statement


INNV Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter June 3.97 % 1.5 % 3.28 % 2.51 %
3rd Quarter March 5.1 % 4.37 % 2.21 % 3.03 %
2nd Quarter December 1.52 % 1.88 % 3.51 % -2.2 %
1st Quarter September 6.63 % 2.88 % 3.18 % -0.95 %
FY (Year on Year)   15.93 % 11.76 % 11.01 % -


Back to INNV Growth rate Comparisons >> Back to INNV Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #125
Healthcare Sector #338
Overall #2348

Revenue Y/Y Growth Statistics
High Average Low
2589.15 % 237.64 % -28.58 %
(Mar 31 2021)   (Dec 31 2015)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #125
Healthcare Sector #338
Overall #2348
Revenue Y/Y Growth Statistics
High Average Low
2589.15 % 237.64 % -28.58 %
(Mar 31 2021)   (Dec 31 2015)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Innovage Holding 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
3562.05 % 145.98 % -58.08 %
(Dec 31 2013)  


INNV's IV. Quarter Q/Q Revenue Comment
Innovage Holding Corp achieved in the IV. Quarter 2025 below company average Revenue growth of 3.97% quarter on quarter, to $ 261.95 millions.

Although the IV. Quarter 2025 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the IV. Quarter surge, eclipses the 1.5% growth in the IV. Quarter a year ago

Within Medical Equipment & Supplies industry 50 other companies have achieved higher Revenue quarter on quarter growth. While Innovage Holding 's Revenue growth quarter on quarter, overall rank is 1246.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #51
Healthcare Sector #180
Overall #1246
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #51
Healthcare Sector #180
Overall #1246
Revenue Q/Q Growth Statistics
High Average Low
3562.05 % 145.98 % -58.08 %
(Dec 31 2013)  


INNV's IV. Quarter Q/Q Revenue Comment
Innovage Holding Corp achieved in the IV. Quarter 2025 below company average Revenue growth of 3.97% quarter on quarter, to $ 261.95 millions.

IV. Quarter 2025 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the 1.5% in the IV. Quarter a year ago.

Within Medical Equipment & Supplies industry 50 other companies have achieved higher Revenue quarter on quarter growth. While Innovage Holding 's Revenue growth quarter on quarter, overall rank is 1246.


Innovage Holding 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 989.71 $ 949.17 $ 915.37 $ 884.66 $ 853.70
Y / Y Revenue Growth (TTM) 15.93 % 14.13 % 13.48 % 12.48 % 11.76 %
Year on Year Revenue Growth Overall Ranking # 1331 # 753 # 58 # 421 # 985
Seqeuential Revenue Change (TTM) 4.27 % 3.69 % 3.47 % 3.63 % 2.65 %
Seq. Revenue Growth (TTM) Overall Ranking # 2348 # 1457 # 119 # 890 # 1714


Cumulative Revenue growth Comment
Although Innovage Holding 's Annual Revenue growth year on year were below company's average 237.64% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 15.93% year on year, from 14.13% in Mar 31 2026.

In the Healthcare sector 227 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 753 to 1331.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 125
Healthcare Sector # 228
Overall # 1331

Revenue TTM Y/Y Growth Statistics
High Average Low
2589.15 %
 237.64 %
-28.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 125
Sector # 338
S&P 500 # 2348
Cumulative Revenue growth Comment
Although Innovage Holding 's Annual Revenue growth year on year were below company's average 237.64% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 15.93% year on year, from 14.13% in Mar 31 2026.

In the Healthcare sector 227 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 753 to 1331.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 125
Healthcare Sector # 228
Overall # 1331

Revenue TTM Y/Y Growth Statistics
High Average Low
2589.15 %
237.64 %
-28.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 125
Sector # 338
S&P 500 # 2348




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
INNV's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue growth for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Corcept Therapeutics Inc31.74%$ 31.743 millions
Establishment Labs Holdings Inc 31.73%$ 31.733 millions
Aclarion Inc 30.48%$ 30.483 millions
Harmony Biosciences Holdings inc 30.42%$ 30.421 millions
Personalis Inc 29.96%$ 29.960 millions
Beone Medicines Ltd 29.69%$ 29.693 millions
Capsovision Inc 29.60%$ 29.598 millions
Intuitive Surgical Inc 29.27%$ 29.272 millions
Xeris Biopharma Holdings Inc 28.74%$ 28.741 millions
Ultragenyx Pharmaceutical Inc 28.53%$ 28.532 millions
Innoviva Inc 28.39%$ 28.391 millions
Electrocore Inc 28.03%$ 28.031 millions
Lightwave Logic Inc 27.91%$ 27.909 millions
American Shared Hospital Services27.15%$ 27.149 millions
Protalix Biotherapeutics inc 27.07%$ 27.066 millions
Alkermes Plc 26.97%$ 26.968 millions
Lucid Diagnostics Inc 26.74%$ 26.741 millions
Lifestance Health Group Inc 26.08%$ 26.076 millions
Ani Pharmaceuticals Inc25.87%$ 25.866 millions
Sight Sciences Inc 25.83%$ 25.830 millions
Grail Inc 25.72%$ 25.723 millions
Fortress Biotech Inc 25.66%$ 25.658 millions
Apyx Medical Corp25.27%$ 25.273 millions
Radnet Inc 24.99%$ 24.986 millions
Precipio inc 24.18%$ 24.178 millions
Krystal Biotech Inc 24.14%$ 24.135 millions
Viemed Healthcare Inc 23.85%$ 23.853 millions
Ardelyx inc 23.77%$ 23.771 millions
Insulet Corporation23.51%$ 23.509 millions
Veracyte Inc 23.45%$ 23.448 millions


About Innovage Holding Revenue Growth Rates (INNV), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.